One-Step Synthesis of Ag Nanoparticles Using Aqueous Extracts from Sundarbans Mangroves Revealed High Toxicity on Major Mosquito Vectors and Microbial Pathogens

Antibacterial, mosquito larvicidal, and cytotoxicity potential of AgNPs synthesized using Pittosporum undulatum under in vitro conditions

In this study, the phytochemical profile and silver nanoparticle (AgNPs)-synthesizing ability of Pittosporum undulatum methanol extract were investigated. Furthermore, biological applications of the AgNPs, such as antibacterial effect (against Klebsiella pneumoniae, Staphylococcus aureus, Bacillus subtilis, and Escherichia coli), mosquito larvicidal effect (against Anopheles stephensi, Culex quinquefasciatus, and Aedes aegypti), and cytotoxicity (against fibroblast cell line L929) were evaluated using in vitro experiments. The phytochemical analysis revealed that the methanol extract contained cardiac glycosides, terpenoids, saponins, alkaloids, flavonoids, glycosides, coumarins, phenolics, and tannins. Furthermore, standard characterization techniques such as UV-Vis spectrometry, SEM, TEM, FTIR, and XRD confirmed that the methanol extract of P. undulatum effectively synthesized the AgNPs. The synthesized AgNPs had a spherical shape and size of 20-200 nm. The bactericidal analysis revealed that the AgNPs have dose-dependent antibacterial activity. The MTT assay showed that the AgNPs were bio-compatible up to a dosage of 250 μg mL-1 in the normal fibroblast cell line L929. Furthermore, the LC50 values for AgNPs against larvae of An. stephensi, Cx. quinquefasciatus, and Ae. aegypti were 0.4, 4.7, and 1.2 ppm, respectively. Field trials demonstrated that the larvicidal effect was enhanced within 24-72 h, and the rate of reduction increased over time. Thus, our findings provide an ideal sustainable AgNP bio-pesticide to combat filarial, dengue, and malaria vectors.

Cardioprotective properties of Artemisia herba alba nanoparticles against heart attack in rats: A study of the antioxidant and hypolipidemic activities

Recently, pharmaceutical scientists' interest has increased to find novel pharmaceutical natural substances with potent antioxidant capacity and very low side effects to be used safely in preventive medicine. One of the most common types of diseases with a large spread globally is cardiovascular diseases, which cause a high rate of deaths annually. The present study evaluated the use of Artemisia herba alba leaves' extract (AHALE) and AHALE zinc oxide nanoparticles (AHALE-ZnONPs) against isoproterenol (ISO) inducing myocardial infarction (MI) in male rats. Several groups of Wistar male rats fed a high-fat diet (HFD) were pretreated with several doses of AHALE or AHALE-ZnONPs for one month followed by exposure to ISO for two days. After treatment, samples of the rats' heart tissues and blood were collected for several molecular biological and biochemical analyses. Heart enzymes, antioxidant enzymes, lipid peroxidation compounds, lipid markers, activities, ROS generation, apoptosis, DNA damage and expression of lipid metabolism genes were analyzed in rats pretreated with AHALE or AHALE-ZnONPs followed by exposure to ISO. The results showed an increase in the levels of AST, ALT, LDH, CK, CK-MB, and cTnT (heart markers), elevation in TG, TC, and LDL levels (lipid profile markers), levels of TBARS and LOOH (lipid peroxidation products), ROS generation, DNA damage, apoptosis, and upregulation of PPAR-α, ADD1, FASN, and ACC genes in animals exposed to ISO in comparison with the control animals. Moreover, a decrease in antioxidant enzyme activities, including GPx, GRx, and GST, was observed in animals exposed to ISO in comparison with control rats. In male rats pretreated with AHALE or AHALE-ZnONPs followed by exposure to ISO, the oxidative stress induced by ISO was prevented. The results suggest that Artemisia extract could be considered for use as one of the natural compounds for prevention of atherosclerosis and heart diseases due to its high antioxidant and hypolipidemic activities. The reduced oxidative stress of Artemisia extract may be a result of the existence of flavonoids and phenolic substances.

Biotechnological applications of mangrove plants and their isolated compounds in medicine-a mechanistic overview

Mangrove plants, also known as halophytes, are ecologically important plants that grow in various tropical and subtropical intertidal regions. Owing to the extreme abiotic and biotic stressful conditions they thrive in, these plants produce unique compounds with promising pharmacological propensities. Mangroves are inhabited by an astronomical number of fungal communities which produce a diverse array of extracellular degradative enzymes, namely: amylase, cellulase, xylanase, pectinase, cholesterol oxidase, etc. Such enzymes can be isolated from the mangrove fungi and harnessed for different biotechnological applications, for example, as replacements for chemical catalysts. Mangrove microbes attract considerable attention as they shelter the largest group of marine microorganisms that are resistant to extreme conditions and can produce novel biogenic substances. Vaccines developed from mangrove microbes may promise a safe future by developing effective immunization procedures with a minimum of economic burden. Interestingly, mangroves offer an exciting opportunity for synthesizing nanoparticles in a greener way as these plants are naturally rich in phytochemicals. Rhizophora mucronata Lam., Avicennia officinalis L. and Excoecaria agallocha L. are capable of synthesizing nanoparticles which have evolved recently as an alternative in various industries and are used for their biomedical application. Besides, the phytoconstituents isolated from mangrove plants, such as: gallic acid, galactose, lupeol, catechins, carotenoids, etc., were explored for various biological activities. These compounds are used in the pharmaceutical and nutraceutical industries to produce antimicrobial, antioxidant, anticancer, antidiabetic, and other therapeutic agents. The present review provides information on the biotechnological potentials of mangrove plants and their bioactive compounds as a new source of novel drugs, enzymes, nanoparticles and therapeutically important microbial pigments. Thus, this review forms a base of support and hasten the urgent research on biomedical applications of mangroves.

SINTESIS NANOPARTIKEL PERAK (NPAg) DENGAN BIOREDUKTOR EKSTRAK BIJI JARAK PAGAR DAN KAJIAN AKTIVITAS ANTIBAKTERINYA

The redox analysis as indicated by a change in color from yellow to reddish-brown was measured at the optimum wavelength of 405 nm with the highest redox result of 480 nm obtained in the NPAg-S sample. The optimal absorption wavelength changes according to the characteristics of the NPAg produced, but is generally in the range of 400-500 nm. Analysis of the active groups with the FTIR instrument showed active groups (OH, CH aldehyde, vibrations of CN bonds in the amine group, amide I groups from proteins, and CO double bonds in the 4000-1500 cm-1) zone. Additionally, in the identification zone 1500-600 cm-1 the formation of CN bond vibrations and the presence of an amide I group from the protein was found. Photographs at 10.000 and 15.000x magnification showed that the morphology of the distribution of NPAg in the jatropha seed extract solution was polydisperse and in the form of fibrous balls with non-uniform particles and tended to agglomerate. The distribution and size of the particles measured using the Particle Size Analyzer (PSA) instrument showed that the particle size ranged from 33-116 nm. NPAg-S samples at two concentrations (1 and 2%) showed inhibitory activity for all types of Gram positive and Gram negative bacteria. Analysis of the particle size distribution using PSA showed that the particle size of the NPAg-S sample was 33.8 nm, which was smaller than the NPAg-K sample of 44.8 nm. Antibacterial activity is strongly influenced by the particle size of a sample. Small size silver nanoparticles have a large surface area to interact with bacteria as compared to large silver nanoparticles, thus they can provide a greater antibacterial effect.

Behavioral and ultrastructural effects of novaluron on Aedes aegypti larvae

Chitin synthesis inhibitors (CSI) are supposed to inhibit formation of chitin microfibrils in newly synthesized cuticle during molting process. Conversely, there has been comparatively few data on morphological effects of CSI on non-target insect organs. In this work, the effects of the CSI novaluron on behavior and midgut of A. aegypti were evaluated. Toxicity bioassays revealed that novaluron is toxic to A. aegypti larva with LC₅₀ = 18.57 mg L^-1 when exposed in aqueous solution for 24 h. Novaluron treated larvae were less active and spent more time resting compared to the control group. Histopathology showed that midguts of novaluron-treated larvae had cytoplasm vacuolization and damaged brush border. Cytotoxic effects in midguts of treated larvae induced necrosis, autophagy and damage to mitochondria. Despite being chitin synthesis inhibitor, novaluron did not induce alterations in the integument of A. aegypti larvae. Fluorescence microscopy revealed that the number of digestive cells were higher in novaluron-treated larvae than in control, in response to digestive cell apoptosis. The present study highlights the importance of novaluron against A. aegypti larvae by causing injuries to non-target organs, altering behaviors, inducing cell death and inhibiting cell proliferation.

Colloidal silver combating pathogenic Pseudomonas aeruginosa and MRSA in chronic rhinosinusitis

The emergence of antibiotic resistant bacteria requires for the development of new antimicrobial compounds one of which colloidal silver (CS) having strong bactericidal properties and being the most promising inorganic nanoparticles for the treatment of bacterial infectious diseases. However, their production can be slow and cumbersome. Here, we used Corymbia maculata aqueous leaf extract as a reducing agent to synthesize CS in a single 15-minute process. CS was physico-chemically characterized for shape, size, zeta potential and stability. The Minimal Inhibitory Concentration (MIC) and Minimum Biofilm Eradication Concentration (MBEC) of CS against planktonic and biofilm forms of methicillin-resistant Staphylococcus aureus (MRSA, n = 5), Pseudomonas aeruginosa (n = 5), Haemophilus influenzae (n = 5) and Streptococcus pneumoniae (n = 3) chronic rhinosinusitis clinical isolates were investigated using the microdilution method and resazurin assay, respectively. The in vitro cytotoxicity on bronchial epithelial cells (Nuli-1) was analyzed by the crystal violet proliferation assay. The safety and efficacy of CS was evaluated in an in vivo infection model in Caenorhabditis elegans. CS was spherical in shape with a diameter of between 11-16 nm (TEM analysis) in dried form and 40 nm (NanoSight) in colloidal form and was stable at room temperature and 4 °C for one year. Average MIC and MBEC values varied between 11 and 44 ppm for MRSA, H. influenzae and S. pneumoniae and between 0.2 and 3 ppm for P. aeruginosa. CS was not toxic to Nuli-1 cells or C. elegans at concentrations of 44 ppm and reduced the Colony Forming Units counts by 96.9 % and 99.6 % in C. elegans for MRSA and P. aeruginosa, respectively. In conclusion, a novel, green synthesis of stable CS is demonstrated with good safety and efficacy profiles, particularly against P. aeruginosa in planktonic and biofilm forms. These CS have potential applications against clinical infections, including in the context of CRS.